chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Violently ill , fever, nausea, chills vomiting , dru-heaving for multiple hours , while bowels moved at the same time. Severe dehydration - lead to a hospitalization at medical center where I recieved phenergren for on going vomiting . Eventually passed  - by hour 24 after dosage.
Dizzy, light headed. Started middle of the night day after shot (night of the 8th). Woke me up multiple times. Spent all day Friday the 9th in a daze. Felt like a flu, but no fever or chills. Slept most the day and work up today (Sat the 10th) feeling close to normal. A few dizzy spells but nothing compared to yesterday.
severe allergic reactions ? non-severe allergic reactions such as rash, itching, hives, or swelling of the face ? myocarditis (inflammation of the heart muscle) ? pericarditis (inflammation of the lining outside the heart) ? injection site pain ? tiredness ? headache ? muscle pain 5 Revised: 29 March 2022 ? chills ? joint pain ? fever ? injection site swelling ? injection site redness ? nausea ? feeling unwell ? swollen lymph nodes (lymphadenopathy) ? decreased appetite ? diarrhea ? vomiting ? arm pain ? fainting in association with injection of the vaccine
Hard, painful lumps on and around injection sites, muscle & bone aching, random severe itching all over body, feet and ankles swelling, rashes in several places (feet, hands, lower legs, ankles), hyponatremia (hospitalized), sudden severe weight gain, increase in depression and anxiety levels, insomnia, sudden weight loss, pain all over, low back pain, flu-like symptoms, constant exhaustion.
Felt really achy; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Felt really achy) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PANTOPRAZOLE, MULTIVITAMINS [VITAMINS NOS], SERTRALINE, LORAZEPAM and TRAZODONE for an unknown indication.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced MYALGIA (Felt really achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (MOTRIN IB) at an unspecified dose and frequency and SUCRALFATE at a dose of 1 gram. At the time of the report, MYALGIA (Felt really achy) had resolved. Not applicable      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Hyper increased hear rate. Up to 164 bpm while resting. Remained very high for 10 + minutes before I passed out for  8 minutes.
as soon as arrived home mom noted bruising, swelling, hard knot; pt c/o pain in arm x 3-4 days; was reluctant to move arm x 3-4 days; 17JUN noted 2' induration & 4" erythema & tender to touch & warm;
Chest pain/Mild chest pain.; This is a spontaneous report from a contactable consumer (parent). A 15-years-old male patient received BNT162B2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: EW0217), via an unspecified route, administered in left arm on 09Jun2021 at 09:45 (at age of 15-years-old) as dose 2, single for COVID-19 immunization. The patient's medical history was not reported. He had no known allergies. Concomitant medication was not reported. He had not received any other vaccine within 4 weeks. He had not received other medications within two weeks. The patient received BNT162B2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: EW0178), via an unspecified route, administered in left arm on 19May2021 at 15:30 (at the age of 14-years-old) as historical vaccine as dose 1, single for COVID-19 immunization. On 09Jun2021 15:00, the patient experienced chest pain/mild chest pain and heart rate was 65bpm. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient did not received treatment for the event. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Oct 12th: Flu vaccine Oct 13th end of day: 36 hours after injection experienced light tingling and numbness in lip and eye.  Oct 14th: onset paralysis and confirmed diagnosis of Bells Palsy  Actively pregnant at the time of injection and onset symptoms.  birth weight 6lbs 10 oz.
This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old male patient with no conditions and no history and no previous illness was vaccinated IM In the left arm with the second dose of GARDASIL (lot # 670049/1171AA, Exp on 11-NOV-2013) at approximately 3:50 PM for nursing visit on 29-MAY-2012. On 29-MAY-2012 the patient felt faint an dizzy 10 minutes after administration and fell to the floor - zero, no injuries sustained. Patient was sweating but denied LOC. Patient was brought back and allowed to lay down for 15 more minutes. The patient's vital signs (V/S) were taken an stable. The original reporting source was not provided. No further information is available.
pt co upper lip tingling 10 minutes after injection, waited another 10 min to see if symptoms resolved.  pt stated lip tingling continues with right arm tingling and tightness across chest.  0.3 EpiPen injection to right thigh.  911 activated. 1:00 injection 1:10 upper lip tingling 1:13 upper lip tingling, right arm tingling, chest tightness 1:13 0.3 EpiPen to right thigh 1:20 Fire arrived 1:30 pt transported to ED
redness at the injection site measuring 10cm, with pain; redness at the injection site measuring 10cm, with pain; This is a spontaneous report received from a contactable reporter(s).  A 17 year-old male patient received meningococcal group b rlp2086 (TRUMENBA), administration date 04Feb2022 (Batch/Lot number: unknown) as dose 1, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05Feb2022, outcome "recovering", VACCINATION SITE ERYTHEMA (non-serious) with onset 05Feb2022, outcome "unknown" and all described as "redness at the injection site measuring 10cm, with pain". Additional information: 17.5 yo male received 1st dose of Trumenba on 04Feb, 30 hours later on 05Feb reported redness at the injection site measuring 10cm, with pain. On 06Feb, redness measured 13cm but less pain. Not other vaccines given on 4 Feb. No history of local vaccine reaction like this. Event took place after use of product. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt had a well check at approx. 10:30am on 5-24-07.  He did not have a temperature, his ears were checked - perfectly clear - and his lungs/breathing were checked - also clear.  He had gained weight since last visit and even though he had a slight runny nose and little cough, was declared healthy enough to get his vaccines.  By approx. 4:30pm on same day, pt had developed a 102 degree fever, was lethargic and was wheezing.  His congestion was also worse.  Called doctor's office, was told if he was wheezing and feverish, to bring in to office.  His temperature at office was still 102 degrees (even though he had been given Tylenol 45 minutes previously).  Pulse oxygen % was taken and it was 98.  Pt had been given a asthma treatment before going to doctor (2 puffs/Albuterol; 2 puffs/Flovent).  Doctor did not hear any wheezing at office.  Doctor did ear check and discovered pt had a double-ear infection.  Prescribed Ciprodex (ear drops) 4 drops twice a day for seven days.  Treatment started that night.  Additionally, given infant motrin for fever.  Pt woke next morning with 103.3 fever and had wet through his pj's.  Pt also developed slight rash on buttocks - small pale red bumps - later that day.
Inpatient administered vaccine at 1700, developed nausea and chest pain at 2300.  Patient given zofran and tylenol - symptoms abated.  Patient with afib, copd, DM, HTN, CRF, UTI.  Beta-blocker stopped on 9/30/08.
He has been getting increasing joint pain in fingers, knees, hips/The joint pain is in his fingers, knees, and hips.; This is painful to move his fingers; This is a spontaneous report from a contactable consumer. A 69-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection; Batch/Lot Number: EL3248) via an unspecified route of administration on 31Jan2021 as single dose for covid-19 immunization. Medical history included diabetes. Concomitant medications included empagliflozin (JARDIANCE) 25mg taken for diabetes mellitus, insulin glargine (LANTUS) (quick pen dosage changes based on readings) taken for diabetes mellitus, start and stop date were not reported. The patient previously received first dose of BNT162B2 (Batch/Lot Number: EL3248) on 13Jan2021 for as DOSE 1, SINGLE for covid-19 immunization. Caller had the Pfizer COVID shot back in Jan2021. Since then, he is getting increasingly worse joint pain. The joint pain is in his fingers, knees, and hips. He has never had it in the past. It is to the point he can barely close his hand. He can't pick up a coffee mug. He went to the doctor. The doctor did x-rays and blood test but couldn't identify a cause. He has had a slight arthritis in the past. This was painful to move his fingers. He heard some stories that this could possibly be related to the COVID shot. He had questions that Is there any information about that. He did not have a prescribing doctor. He never connected it to the shot at first. But it all started after the shot and continued getting worse and worse. The first shot was 13Jan2021 with lot number EL3248. The second shot was 31Jan2021 with the same lot number EL3248. He doesn't know which arms he got them in. The second one was in the morning, and the first one was in the afternoon. He went to Hospital . The first one was at 1 o'clock. He is on medicine for diabetes. Jardiance 25mg, Injectionquick pen dosage changes based on readings. The outcome of the event joint pain in fingers, knees, hips was not recovered, and outcome was unknown for the event painful to move his fingers.  Information about Lot and batch was available. Further information was expected.
Since 2015 I have had a neurological condition (numbness and tingling below the waist); at first there was concern about Guillen-Barre, but that was ruled out. My neurologist mentioned that this was an autoimmune condition and had been triggered by a brief flu with fever which I had had 2 weeks before hte onset of neurological symptoms; he said this kind of timing was very typical. Since then I have not had a fever. The numbness and tingling have varied somewhat in intensity but never gone away.  three weeks after the vaccine I had a bigger increase in the numbness and tingling than during all the years I have had this condition. This made me reconsider getting the second vaccine (see continuation page)....... This made me reconsider getting the second vaccine since 1)this was just like the timing mentioned by the neurologist, who had also warned me that my condition could worsen and a leg might collapse under me, or I might lose bowel or bladder control. The symptoms people get after the second dose are usually worse. 2) if the vaccine stresses my immune system by a strong autoimmune reaction, the little bit of Covid protection I get from the vaccine is not going to make up for it (a recent headline announced that after the Delta variant, its effectiveness is only 66%, presumably much less in the senior population, say 33%).  It seems likely to me that getting the vaccine will only increase my chances of getting a bad case of Covid, and of spreading it to others.  As regards to the neurological symptoms alone, no treatment was sought or given (my neurologist said I did not need to see him unless something more drastic happened or seemed imminent).  At the same time as the neurological symptoms worsened, I developed other problems which I had in 2015 and haven't had for a long time. Five alternative practitioners have attributed these to Lyme, and the neurological symptoms as well: swelling  behind the knees (sometimes enough to interfere with wa lking), chest pressure (possibly costochondritis), slight shortness of breath on walking uphill (possibly heart.) Recently I was able to see one of these practitioners, who confirmed that I had a reactivation of Lyme, which had been well under control when I saw her in June. She added that other, less obvious problems had developed as well, that my immune system was down, and that she has seen a number of such cases with aggravation of preexisting illness following Covid vaccination. Again, I concluded that since the vaccine makes me sick with reactivation of a systemic infection, there is no point in my getting a second dose of vaccine.
pt recv vax & 36hr later vomited, has no fever & is fussy for a week;tx Pedialyte & suppository;
Moderna COVID-19 Vaccine EUA -  Tingling all the way down my left arm within 15 minutes of injection. Tingling in my neck and shoulder within 30 minutes of injection. Tingling in my left cheek and left side of lips within 45 minutes of injection. The tingling turned to numbness on left cheek and left side of lips. 14 hours after injection most of the feeling was back in my cheek but left corner of mouth was still numb and tingly. 3 weeks later and the left corner of my lips still feels slightly tingly and numb.
PNEUMOVAX 23 that experienced an excursion was administered to a patient; This spontaneous report was received from a consumer referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.       On 14-SEP-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # reported as T00744 was evaluated and changed to the valid lot # T009744, expiration date 28-JAN-2022; strength, dose and route were not reported) that experienced an excursion for prophylaxis (product storage error). Temperature excursion was below 2 degree Celsius (1.7 degree Celsius) for 2 hours. There was no previous temperature excursion. Data logger was involved.        combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: T009744; expirationdate: 28-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
A 4 year old was given DTaP in the left arm IM and Prevnar in the right are IM on 01/11/05 She was seen on 01/13/05 with localized red rash on the left arm (7x6cm) and right arm (5x4cm). Left arm rash started evening of 01/12/05 and right arm rash the morning of 01/13/05.
Patient administered 0.5mL dose instead of 0.25mL booster dose for their fourth dose in the series.
I didn?t have an adverse reaction to the vaccine. I tested positive for Covid-19 on 7/4/22
Surgery; Surgery interrupted 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (Surgery) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SURGERY (Surgery) (seriousness criterion medically significant) and INCOMPLETE COURSE OF VACCINATION (Surgery interrupted 2nd shot). At the time of the report, SURGERY (Surgery) and INCOMPLETE COURSE OF VACCINATION (Surgery interrupted 2nd shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by reporter. Treatment information was not applicable.  Very limited information regarding the events has been provided at this time. No further information is expected. Based on current available information and the temporal association between product use and the start date of the event a causal relationship is unlikely.; Sender's Comments: Very limited information regarding the events has been provided at this time. No further information is expected. Based on current available information and the temporal association between product use and the start date of the event a causal relationship is unlikely.
10-days after vaccine injection - nausea, vommiting, diarrhea, instesinal cramps, blood in stool.  Went to the Emergency Room then admitted to the hospital for 2.5 days.  Blood tests, stool tests and CT scan of GI tract all came back negative.  Fully recovered after 5 days.
Narrative:  Patient received COVID Booster 11/16/21. Patient tested positive for COVID 12/14/21. Patient was given Bamlanivimab + Etesevimab 12/17/21. Patient was admitted for COVID + / immunocompromised state 12/22/21.
This case was reported by a healthcare professional and described the occurrence of injection site pain in a subject of unspecified age and gender who was vaccinated with Flulaval for prophylaxis. On an unspecified date, on or prior to 05 February 2007, the subject received an unspecified dose of Flulaval. At an unspecified time after vaccination with Flulaval, the subject experienced severe pain at injections site, nausea, fever, aches and pain, and pharmaceutical product complaint. The events lasted for three days. The reporter indicated that there were approximately six other patients who
3/3/2019 Onset - present  lightheaded & dizzy cold & tingling extreme heart palpitations poor concentration weakness tiredness difficult exercising gastrointestinal symptoms anxiety
Information has been received from a consumer concerning her 18 month old daughter with no medical history who on 10-OCT-2006 was vaccinated with a first dose of VAQTA.  Concomitant therapy included TYLENOL.  On 12-OCT-2006, 40 hours after vaccination with VAQTA, the subject experienced regression in development, speech deterioration, screaming, and grunting.  On unspecified dates in December of 2006, the subject experienced periods of immobility or paralysis, which occurred on two separate episodes.  On 10-APR-2007, the subject received the 2nd dose of VAQTA (unknown) and experienced five episodes of immobility within the next six months.  The reporter reported that her daughter was diagnosed with mild autism (date of diagnosis unspecified).  It was reported that a physician or other health care professional has not verified this report.  The subject's mother considered the events to be disabling.  The subject's mother stated that she is in the early stages of investigating vaccines that her daughter has received which may contain ingredients the child may be allergic to.  Per the subject's mother, there were no signs of regression until 12-OCT-2006.  At the time of the report, the child has been in therapy for 19 months and her condition has improved, but she remains behind her peers.  The patient's vaccination history included a third dose of ENGERIX B given in the left thigh on 21-OCT-2005.
STORAGE REFRIGERATOR (2C-8C) UP TO 30 DAYS. (VACCINE USED AFTER 10-16-2021)
5/5/2021 57 y/o female with past medical of hypertension and anxiety, who presents with headache, dizziness and lightheadedness post vaccination. Patient states that this is her 2nd dose in the two-dose series. Patient states that with the first vaccination she experienced fever, headache, chills and tiredness. Patient states that she received her vaccination to the Left arm. NP and Paramedics at patient side. Patient placed on wheelchair and vital assessed. Patient BP 180/100 R arm, 98% RA, 75 P. Patient states that she took Metoprolol this am but forgot to take her Hydrochlorothiazide. Patient also states that she fears needles. Patient was monitored with repeat vitals and patient remained hypertensive, 179/102 BP, 213/116, 189/109, 187/107, 197/110, 208/110 with all other vitals within normal limits. Within 20 mins of monitoring patient it was determined that patient should be transported to the emergency room via fire rescue. Fire rescue arrived on scene, advised patient that she should be transported to the ER but the patient refused. Patient aware of the risks involved, such as hypertensive crisis, stroke or cardiac event. Patient signed out Against Medical Advice. CNO and PM aware.
After 10 days of the booster shot, I started to have rash, hives and itch around my body. Went to ER and the gave me steroids (didn't work well). after I went to an allergist and started to take zyxol and allegra
Sneezing; Running nose; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing) and RHINORRHOEA (Running nose) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced SNEEZING (Sneezing) and RHINORRHOEA (Running nose). At the time of the report, SNEEZING (Sneezing) and RHINORRHOEA (Running nose) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
p/vax pt devel a rash which subsequently resolved;8/26/98 rash reappeared;the reporting MD felt that rash was r/t vax;
Within one hour post vax, the pt experienced head pressure, flushing of face, trunk and arms, upper body achiness, eye irritation without redness or drainage, and malaise.
7AUG91 crying between 6 & 9PM; Hospital called at 8PM they told family "rxn" was normal & return call if pt didn't go to sleep soon; crying stopped 9PM & pt went to sleep;
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. No information regarding their current conditions and medical history was provided by the reporter. On an unknown date since 30-DEC-2015, the patients were vaccinated with improperly stored ROTATEQ (strength, dose, route and indication not reported) of lot # L020859 and expiry date: 19-JAN-2017. Concomitant medications were not mentioned. The vaccine was stored at 58.5 degree Fahrenheit for a time frame of 24 hours which was outside of the recommended range (incorrect product storage) and administered to patients. There was no previous temperature excursion. No adverse effects have been reported. No additional information was provided. Product Quality complaint was not filed. Additional information has been requested. This is one of the five reports received from the same reporter.
When administering vaccine into right arm resistance was met and only 0.2 ml of vaccine was able to be injected.  Upon speaking to the patient, she reported that she does get bi-weekly haldol injections in that arm.  Per cdc recommendations, dose was repeated in opposite arm and full dose was given.
Severe pain in (R) shoulder & injection site w/in several hrs of receiving vaccine. Has needed steroid injection & PT & still has not resolved.
Patient called the day after receiving the vaccination complaining of body aches, injection site had a bump, redness and was hurting. She also stated that she had a headache. We attempted to contact the patient on 8/8/19 to see if her symptoms had resolved but have not been able to reach her.
swollen arm, red, fever T104, severe arm discomfort, hot dizziness, T100.8 on 23OCT95;Tetracycline started 22OCT95